克罗恩病中的便和血清代谢与未来的爆发有关
Nina Levhar1,2, Rotem Hadar1, Tzipi Braun1
1Sheba Medical Center, Tel-Hashomer, Affiliated With the Tel Aviv University, Tel Aviv, Israel.
United European gastroenterology journal
|July 12, 2025
概括
克罗恩病 (CD) 患者的代谢物水平可以预测未来的爆发. 特定的肠道和血液代谢物变化,包括更高的尿酸盐,被确定为预测CD爆发的关键指标.
科学领域:
- 胃肠病学 胃肠病学
- 代谢学 代谢学 代谢学
- 炎症性肠道疾病研究研究
背景情况:
- 代谢物在生理功能中起着至关重要的作用.
- 关于代谢物水平与未来克罗恩病 (CD) 爆发之间的关联存在有限的数据.
研究的目的:
- 为了确定CD爆发之前的全身和肠道代谢变化.
- 开发基于代谢物的指数来预测CD爆发,在独立的队列中得到验证.
主要方法:
- 对静止性CD患者的血清和便代谢物的前性分析.
- 监测患者的临床爆发或研究完成.
- 使用代谢特征的预测模型的开发和验证.
主要成果:
- 在CD患者中确定了发作前的代谢变化,包括便中的碳水化合物和脂肪酸变化.
- 在爆发前的样本中观察到血清3-基酸盐和乙酸盐的降低,尿酸盐的升高.
- 在一个独立的队列中验证了便代谢学预测;使用血清尿酸与肌素的比率和CRP开发了一个预测指数.
结论:
- 在CD爆发之前的代谢变化为疾病机制提供了洞察力.
- 代谢物概况可以潜在地识别患CD爆发风险较高的个体.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
426
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426
Inflammatory Bowel Disease II: Crohn's Disease
392
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
392
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
272
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
272
Serum Laboratory Studies, Stool Test, Breath Test
476
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
476
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237
Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541


